Mark P. Wentland - Publications

Affiliations: 
Rensselaer Polytechnic Institute, Troy, NY, United States 
Area:
Medications to Treat Addictive Disorders
Website:
http://www.rpi.edu/dept/chem/chem_faculty/profiles/wentland.html

69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Hoerbelt P, Nalwalk JW, Phillips JG, Wentland MP, Shan Z, Hough LB. Antinociceptive activity of CC44, a biotinylated improgan congener. European Journal of Pharmacology. 714: 464-71. PMID 23834775 DOI: 10.1016/j.ejphar.2013.06.041  0.8
2013 VanAlstine MA, Wentland MP, Alvarez J, Cao Q, Cohen DJ, Knapp BI, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 9: Synthesis, characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1), a high affinity ligand for opioid receptors. Bioorganic & Medicinal Chemistry Letters. 23: 2128-33. PMID 23434225 DOI: 10.1016/j.bmcl.2013.01.117  0.8
2012 Yang J, VanAlstine MA, Phillips JG, Wentland MP, Hough LB. Cytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition. Acta Pharmaceutica Sinica. B. 2: 137-145. PMID 25068100 DOI: 10.1016/j.apsb.2012.02.003  0.4
2012 Wentland MP, Jo S, Gargano JM, VanAlstine MA, Cohen DJ, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC. Bioorganic & Medicinal Chemistry Letters. 22: 7340-4. PMID 23142613 DOI: 10.1016/j.bmcl.2012.10.081  0.8
2012 Porter DC, Farmaki E, Altilia S, Schools GP, West DK, Chen M, Chang BD, Puzyrev AT, Lim CU, Rokow-Kittell R, Friedhoff LT, Papavassiliou AG, Kalurupalle S, Hurteau G, Shi J, ... ... Wentland MP, et al. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proceedings of the National Academy of Sciences of the United States of America. 109: 13799-804. PMID 22869755 DOI: 10.1073/pnas.1206906109  0.8
2011 Hough LB, Nalwalk JW, Yang J, Conroy JL, VanAlstine MA, Yang W, Gargano J, Shan Z, Zhang SZ, Wentland MP, Phillips JG, Knapp BI, Bidlack JM, Zuiderveld OP, Leurs R, et al. Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic. Pain. 152: 878-87. PMID 21316152 DOI: 10.1016/j.pain.2011.01.001  0.8
2010 Conroy JL, Fang C, Gu J, Zeitlin SO, Yang W, Yang J, VanAlstine MA, Nalwalk JW, Albrecht PJ, Mazurkiewicz JE, Snyder-Keller A, Shan Z, Zhang SZ, Wentland MP, Behr M, et al. Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling. Nature Neuroscience. 13: 284-6. PMID 20139973 DOI: 10.1038/nn.2497  0.8
2009 Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, Ganorkar R, VanAlstine MA, Guo C, Cohen DJ, Bidlack JM. Syntheses of novel high affinity ligands for opioid receptors. Bioorganic & Medicinal Chemistry Letters. 19: 2289-94. PMID 19282177 DOI: 10.1016/j.bmcl.2009.02.078  0.8
2009 Wentland MP, Lu Q, Ganorkar R, Zhang SZ, Jo S, Cohen DJ, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: Syntheses and opioid receptor properties of cyclic variants of cyclazocine Bioorganic and Medicinal Chemistry Letters. 19: 365-368. PMID 19091564 DOI: 10.1016/j.bmcl.2008.11.076  0.8
2009 Wentland MP, Lou R, Lu Q, Bu Y, VanAlstine MA, Cohen DJ, Bidlack JM. Syntheses and opioid receptor binding properties of carboxamido-substituted opioids. Bioorganic & Medicinal Chemistry Letters. 19: 203-8. PMID 19027293 DOI: 10.1016/j.bmcl.2008.10.134  0.8
2008 Wentland MP, Sun X, Cohen DJ, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine Bioorganic and Medicinal Chemistry. 16: 5653-5664. PMID 18417347 DOI: 10.1016/j.bmc.2008.03.066  0.8
2007 VanAlstine MA, Wentland MP, Cohen DJ, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4′-phenyl)-phenethyl) analogues of 8-CAC Bioorganic and Medicinal Chemistry Letters. 17: 6516-6520. PMID 17935988 DOI: 10.1016/j.bmcl.2007.09.082  0.8
2007 Hough LB, Nalwalk JW, Phillips JG, Kern B, Shan Z, Wentland MP, de Esch IJ, Janssen E, Barr T, Stadel R. CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist. Neuropharmacology. 52: 1244-55. PMID 17336343 DOI: 10.1016/j.neuropharm.2007.01.004  0.8
2006 Wentland MP, VanAlstine M, Kucejko R, Lou R, Cohen DJ, Parkhill AL, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3- benzazocines. 4. Opioid receptor binding properties of 8-[n-(4′-phenyl)- phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine Journal of Medicinal Chemistry. 49: 5635-5639. PMID 16942039 DOI: 10.1021/jm060278n  0.8
2006 Wagman AS, Wentland MP. Quinolone antibacterial agents Comprehensive Medicinal Chemistry Ii. 7: 667-696.  0.8
2005 Hough LB, Nalwalk JW, Lu Q, Shan Z, Svokos K, Wentland MP, Montero MJ. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic. European Journal of Pharmacology. 522: 38-46. PMID 16216240 DOI: 10.1016/j.ejphar.2005.08.040  0.8
2005 Wentland MP, Sun X, Bu Y, Lou R, Cohen DJ, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocine. Bioorganic & Medicinal Chemistry Letters. 15: 2547-51. PMID 15863314 DOI: 10.1016/j.bmcl.2005.03.056  0.8
2005 Wentland MP, Lu Q, Lou R, Bu Y, Knapp BI, Bidlack JM. Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone. Bioorganic & Medicinal Chemistry Letters. 15: 2107-10. PMID 15808478 DOI: 10.1016/j.bmcl.2005.02.032  0.8
2004 Stevenson GW, Wentland MP, Bidlack JM, Mello NK, Negus SS. Effects of the mixed-action kappa/mu opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys. European Journal of Pharmacology. 506: 133-41. PMID 15588733 DOI: 10.1016/j.ejphar.2004.10.051  0.8
2004 Gekker G, Hu S, Wentland MP, Bidlack JM, Lokensgard JR, Peterson PK. κ-Opioid Receptor Ligands Inhibit Cocaine-Induced HIV-1 Expression in Microglial Cells Journal of Pharmacology and Experimental Therapeutics. 309: 600-606. PMID 14757849 DOI: 10.1124/jpet.103.060160  0.8
2004 Zhang A, Xiong W, Bidlack JM, Hilbert JE, Knapp BI, Wentland MP, Neumeyer JL. 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors. Journal of Medicinal Chemistry. 47: 165-74. PMID 14695830 DOI: 10.1021/jm0304156  0.8
2004 Wentland MP, Raza S, Gao Y. 96-Well plate colorimetric assay for Ki determination of (±)-2-Benzylsuccinic acid, an inhibitor of carboxypeptidase A. A laboratory experiment in drug discovery Journal of Chemical Education. 81: 398-400.  0.8
2003 Zhou Q, Duan WH, Cohen DJ, Bidlack JM, Wentland MP. Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl) methyl] benzomorphan Yaoxue Xuebao. 38: 748-753. PMID 14730897  0.8
2003 Wentland MP, Sun X, Ye Y, Lou R, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-Formamidocyclazocine analogues Bioorganic and Medicinal Chemistry Letters. 13: 1911-1914. PMID 12749896 DOI: 10.1016/S0960-894X(03)00295-6  0.8
2003 Wentland MP, Ye Y, Cioffi CL, Lou R, Zhou Q, Xu G, Duan W, Dehnhardt CM, Sun X, Cohen DJ, Bidlack JM. Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines Journal of Medicinal Chemistry. 46: 838-849. PMID 12593663 DOI: 10.1021/jm020429w  0.8
2003 Lou R, VanAlstine M, Sun X, Wentland MP. Preparation of N-hydroxysuccinimido esters via palladium-catalyzed carbonylation of aryl triflates and halides Tetrahedron Letters. 44: 2477-2480. DOI: 10.1016/S0040-4039(03)00337-X  0.8
2002 Bidlack JM, Cohen DJ, McLaughlin JP, Lou R, Ye Y, Wentland MP. 8-Carboxamidocyclazocine: A long-acting, novel benzomorphan Journal of Pharmacology and Experimental Therapeutics. 302: 374-380. PMID 12065740 DOI: 10.1124/jpet.302.1.374  0.8
2001 Wentland MP, Lou R, Dehnhardt CM, Duan W, Cohen DJ, Bidlack JM. 3-Carboxamido analogues of morphine and naltrexone: Synthesis and opioid receptor binding properties Bioorganic and Medicinal Chemistry Letters. 11: 1717-1721. PMID 11425545 DOI: 10.1016/S0960-894X(01)00278-5  0.8
2001 Wentland MP, Lou R, Ye Y, Cohen DJ, Richardson GP, Bidlack JM. 8-Carboxamidocyclazocine analogues: Redefining the structure-activity relationships of 2,6-methano-3-benzazocines Bioorganic and Medicinal Chemistry Letters. 11: 623-626. PMID 11266156 DOI: 10.1016/S0960-894X(01)00014-2  0.8
2000 Wentland MP, Duan W, Cohen DJ, Bidlack JM. Selective protection and functionalization of morphine: Synthesis and opioid receptor binding properties of 3-amino-3-desoxymorphine derivatives Journal of Medicinal Chemistry. 43: 3558-3565. PMID 11000010 DOI: 10.1021/jm000119i  0.8
2000 Bidlack JM, McLaughlin JP, Wentland MP. Partial opioids. Medications for the treatment of pain and drug abuse Annals of the New York Academy of Sciences. 909: 1-11. PMID 10911920  0.8
2000 Wentland MP, Xu G, Cioffi CL, Ye Y, Duan W, Cohen DJ, Colasurdo AM, Bidlack JM. 8-Aminocyclazocine analogues: Synthesis and structure-activity relationships Bioorganic and Medicinal Chemistry Letters. 10: 183-187. PMID 10673107  0.8
1999 Potts KT, Wentland MP, Ganguly D, Storrier GD, Cha SK, Cha J, Abruña HD. Multimetallic, double-stranded helical complexes derived from hexa(n-propylthio)novipyridine: Synthesis, structure and redox properties Inorganica Chimica Acta. 288: 189-199.  0.8
1998 Perni RB, Wentland MP, Huang JI, Powles RG, Aldous S, Klingbeil KM, Peverly AD, Robinson RG, Corbett TH, Jones JL, Mattes KC, Rake JB, Coughlin SA. Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives. Journal of Medicinal Chemistry. 41: 3645-54. PMID 9733489 DOI: 10.1021/jm9708083  0.8
1998 Wentland MP, Hildbrand S, Blaser A, Parel SP, Leumann CJ. 5-Substituted 2-aminopyridine C-nucleosides as protonated cytidine equivalents: Increasing efficiency and selectivity in DNA triple-helix formation Chemtracts. 11: 274-281.  0.8
1998 Wentland MP. Ras farnesyltransferase inhibitors Drug Discovery Today. 3: 45.  0.8
1997 Wentland MP, Perni RB, Dorff PH, Brundage RP, Castaldi MJ, Carlson JA, Bailey TR, Aldous SC, Carabateas PM, Bacon ER, Kullnig RK, Young DC, Woods MG, Kingsley SD, Ryan KA, et al. Antiviral properties of 3-quinolinecarboxamides: a series of novel non-nucleoside antiherpetic agents. Drug Design and Discovery. 15: 25-38. PMID 9332829  0.8
1997 Pechulis AD, Archer S, Wentland MP, Colasurdo AM, Bidlack JM. Arylacetamide Kappa-selective opioid ligands Bioorganic and Medicinal Chemistry Letters. 7: 2273-2276.  0.8
1996 Wentland MP, Perni RB, Huang JI, Powles RG, Aldous SC, Klingbeil KM, Peverly AD, Robinson RG, Corbett TH, Jones JL, Rake JB, Coughlin SA. Cyclic variations of SR 233377 (WIN 33377) and effects on antitumor activity Bioorganic and Medicinal Chemistry Letters. 6: 1345-1350. DOI: 10.1016/0960-894X(96)00230-2  0.8
1995 Huff AC, Robinson RG, Evans AC, Selander KN, Wentland MP, Rake JB, Coughlin SA. DNA sequence preferences at sites cleaved by human DNA topoisomerase II in response to novel quinolone derivatives. Anti-Cancer Drug Design. 10: 251-76. PMID 7748459  0.8
1995 Wentland MP, Carlson JA, Dorff PH, Aldous SC, Perni RB, Young DC, Woods MG, Kingsley SD, Ryan KA, Rosi D, Drozd ML, Dutko FJ. Cyclic variations of 3-quinolinecarboxamides and effects on antiherpetic activity Journal of Medicinal Chemistry. 38: 2541-2545. PMID 7629793  0.8
1995 Reuman M, Daum SJ, Singh B, Wentland MP, Perni RB, Pennock P, Carabateas PM, Gruett MD, Saindane MT, Dorff PH, Coughlin SA, Sedlock DM, Rake JB, Lesher GY. Synthesis and antibacterial activity of some novel 1-substituted 1,4-dihydro-4-oxo-7-pyridinyl-3-quinolinecarboxylic acids. Potent antistaphylococcal agents Journal of Medicinal Chemistry. 38: 2531-2540. PMID 7629792  0.8
1995 Coughlin SA, Danz DW, Robinson RG, Klingbeil KM, Wentland MP, Corbett TH, Waud WR, Zwelling LA, Altschuler E, Bales E. Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H- pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161). Biochemical Pharmacology. 50: 111-22. PMID 7605336 DOI: 10.1016/0006-2952(95)00016-S  0.8
1995 Eissenstat MA, Kuo GH, Weaver JD, Wentland MP, Robinson RG, Klingbeil KM, Danz DW, Corbett TH, Coughlin SA. 3-benzyl-quinolones: Novel, potent inhibitors of mammalian topoisomerase II Bioorganic and Medicinal Chemistry Letters. 5: 1021-1026. DOI: 10.1016/0960-894X(95)00160-U  0.8
1995 Wentland MP, Aldous SC, Gruett MD, Perni RB, Powles RG, Danz DW, Klingbeil KM, Peverly AD, Robinson RG, Corbett TH, Rake JB, Coughlin SA. The antitumor activity of novel pyrazoloquinoline derivatives Bioorganic and Medicinal Chemistry Letters. 5: 405-410. DOI: 10.1016/0960-894X(95)00044-T  0.8
1995 Kuo GH, Eissenstat MA, Wentland MP, Robinson RG, Klingbeil KM, Danz DW, Coughlin SA. Potent mammalian topoisomerase II inhibitors: 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-su bstituted-quinolines Bioorganic and Medicinal Chemistry Letters. 5: 399-404. DOI: 10.1016/0960-894X(95)00043-S  0.8
1994 Corbett T, Lowichik N, Pugh S, Polin L, Panchapor C, White K, Knight JW, Demchik L, Jones J, Jones L, Biernat L, Lorusso P, Foster B, Heilbrun L, Rake J, ... ... Wentland MP, et al. Antitumour activity of n-[[1-[[2-(diethylamino)ethyl]amino]-9-oxo-9h-thioxanthen-4-yl]methyl]methanesulfonamide (WIN33377) and analogues Expert Opinion On Investigational Drugs. 3: 1281-1292. DOI: 10.1517/13543784.3.12.1281  0.8
1994 Wentland MP, Perni RB, Powles RG, Hlavac AG, Mattes KC, Corbett TH, Couhglin SA, Rake JB. Anti-solid tumor efficacy and preparation of N-[[1-[[2-(diethylamino)ethyl]amino]-9-oxo-9H-thioxanthen-4-yl]methyl]me thanesulfonamide (win 33377) and related derivatives Bioorganic and Medicinal Chemistry Letters. 4: 609-614. DOI: 10.1016/S0960-894X(01)80164-5  0.8
1993 Wentland MP, Lesher GY, Reuman M, Gruett MD, Singh B, Aldous SC, Dorff PH, Rake JB, Coughlin SA. Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivatives. Journal of Medicinal Chemistry. 36: 2801-9. PMID 8410993  0.8
1993 Wentland MP, Perni RB, Dorff PH, Brundage RP, Castaldi MJ, Bailey TR, Carabateas PM, Bacon ER, Young DC, Woods MG. 3-Quinolinecarboxamides. A series of novel orally-active antiherpetic agents. Journal of Medicinal Chemistry. 36: 1580-96. PMID 8388470  0.8
1993 Wentland MP, Lesher GY, Reuman M, Pilling GM, Saindane MT, Perni RB, Eissenstat MA, Weaver JD, Singh B, Rake J, Coughlin SA. Relationship of structure of bridged (2,6-dimethyl-4-pyridinyl)quinolones to mammalian topoisomerase II inhibition Bioorganic and Medicinal Chemistry Letters. 3: 1711-1716. DOI: 10.1016/S0960-894X(00)80048-7  0.8
1991 Wentland MP, Kullnig RK, Tham FS. Synthesis of aza macrocycles from polycyclic 5-aminoisoxazoline precursors Journal of Organic Chemistry. 56: 4701-4706.  0.8
1989 Wentland MP. The synthesis of novel nitrogen-containing macrocycles from isoxazoline intermediates Tetrahedron Letters. 30: 1477-1478. DOI: 10.1016/S0040-4039(00)99495-4  0.8
1989 Wentland MP, Hansen PE, Schow SR, Daum SJ. An efficient method for the synthesis of 4-benzoylthioazetidinones Tetrahedron Letters. 30: 6619-6620. DOI: 10.1016/S0040-4039(00)70633-2  0.8
1988 Wentland MP, Bailey DM, Powles RG, Slee AM, Sedlock DM. The in vitro dental plaque inhibitory properties of a series of N-[1-alkyl-4(1H )-pyridinylidene]alkylamines Journal of Medicinal Chemistry. 31: 2024-2027. PMID 3172139  0.8
1988 Wentland MP, Perni RB, Dorff PH, Rake JB. Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative Journal of Medicinal Chemistry. 31: 1694-1697. PMID 2842501  0.8
1987 Wentland MP, Bailey DM, Alexander EJ, Castaldi MJ, Ferrari RA, Haubrich DR, Luttinger DA, Perrone MH. Synthesis and antidepressant properties of novel 2-substituted 4,5-dihydro-1H-imidazole derivatives. Journal of Medicinal Chemistry. 30: 1482-9. PMID 3039138  0.8
1986 Cornett JB, Wentland MP. Chapter 14. Quinolone Antibacterial Agents Annual Reports in Medicinal Chemistry. 21: 139-148. DOI: 10.1016/S0065-7743(08)61124-0  0.8
1985 Cornett JB, Wagner RB, Dobson RA, Wentland MP, Bailey DM. In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin). Antimicrobial Agents and Chemotherapy. 27: 4-10. PMID 3885845  0.8
1985 Wentland MP, Cornett JB. Chapter 15. Quinolone Antibacterial Agents Annual Reports in Medicinal Chemistry. 20: 145-154. DOI: 10.1016/S0065-7743(08)61041-6  0.8
1984 Wentland MP, Bailey DM, Cornett JB, Dobson RA, Powles RG, Wagner RB. Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships. Journal of Medicinal Chemistry. 27: 1103-8. PMID 6381730  0.8
1980 Wentland MP, Albertson NF, Pierson AK. Synthesis and pharmacology of 8-amino-3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-2,6-methano-3-benzazocine and related compounds. Journal of Medicinal Chemistry. 23: 71-4. PMID 7359514  0.8
1971 Stevens RV, Christensen CG, Edmonson WL, Kaplan M, Reid EB, Wentland MP. Studies on the synthesis of corrins and related ligands. I. General approach and model studies Journal of the American Chemical Society. 93: 6629-6637.  1
1971 Stevens RV, DuPree LE, Edmonson WL, Magid LL, Wentland MP. Studies on the synthesis of corrins and related ligands. II. The employment of isoxazoles in the synthesis of semicorrins Journal of the American Chemical Society. 93: 6637-6643.  1
1970 Stevens RV, Dupree LE, Wentland MP. Studies on the synthesis of corrins and related ligands. Employment of isoxazoles as intermediates in the synthesis of semicorrins Journal of the Chemical Society D: Chemical Communications. 821-822. DOI: 10.1039/C29700000821  1
1968 Stevens RV, Wentland MP. Thermal rearrangement of cyclopropyl imines. IV. Total synthesis of dl-mesembrine Journal of the American Chemical Society. 90: 5580-5583. PMID 5679163  1
1968 Stevens RV, Ellis MC, Wentland MP. Thermal rearrangement of cyclopropyl imines. 3. Total synthesis of pyridine alkaloids. Journal of the American Chemical Society. 90: 5576-5579. PMID 5679162  1
1968 Stevens RV, Wentland MP. Thermal rearrangement of cyclopropyl imines. II. Synthesis of a mesembrine model Tetrahedron Letters. 9: 2613-2615. PMID 5646262  1
1968 Stevens RV, Wentland MP. The total synthesis of (±)-15,16-dimethoxyerythrinan-3-one. A further application of the methyl vinyl ketone annelation of endocyclic enamines Chemical Communications (London). 1104-1105. DOI: 10.1039/C19680001104  1
Show low-probability matches.